This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Talmor, D. Articles by Tirosh, A. Search for Related Content PubMed PubMed Citation Articles by Talmor, D. Articles by Tirosh, A. Related Collections Animal models of human disease Ischemic biology - basic studies CV surgery: coronary artery disease Oxidant stress

(Circulation Research. 2000;86:1004.)
© 2000 American Heart Association, Inc.

Clinical Research

Activation of Mitogen-Activated Protein Kinases in Human Heart During Cardiopulmonary Bypass

Daniel Talmor, Azai Applebaum, Assaf Rudich, Yoram Shapira, Amir Tirosh

From the Division of Anesthesiology (D.T., Y.S.), Department of Cardiothoracic Surgery (A.A.), The S. Daniel Abraham Center for Health and Nutrition (A.R.), and the Department of Clinical Biochemistry (A.T.), Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Correspondence to Amir Tirosh, MD, Department of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel, IL-84105. E-mail amirt{at}bgumail.bgu.ac.il

Abstract—Mitogen-activated protein kinases (MAPKs) have been shown to be activated in both in vitro and in vivo models of cardiac tissue in response to ischemia/reperfusion injury. We investigated whether MAPKs are activated in human heart during coronary artery bypass grafting (CABG) surgery. During elective CABG surgery of 8 patients, 3 right atrial appendage biopsies were obtained at baseline, at the end of cross-clamping, and after coronary reperfusion. The expression of the p38-MAPK, c-Jun N-terminal kinase (JNK), and extracellular signal–regulated kinases (ERK1/2) MAPKs was not altered during CABG. The phosphorylation and activation of both ERK1/2 and p38-MAPK were increased 2-fold by ischemia and even more (8- and 4-fold, respectively) by reperfusion. Although the ischemic period did not result in a significant activation of JNK, an 6-fold increase in JNK activity could be observed after reperfusion. In conclusion, distinct activation patterns of ERK1/2, p38, and JNK MAPKs can be observed in human heart during CABG.

Key Words: myocardium • ischemia/reperfusion • stress-activated protein kinases

This article has been cited by other articles:

				R. T. Clements, N. R. Sodha, J. Feng, S. Mieno, M. Boodhwani, B. Ramlawi, C. Bianchi, and F. W. Sellke Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1461 - 1470.e3. [Abstract] [Full Text] [PDF]

				O. J. Liakopoulos, J. D. Schmitto, S. Kazmaier, A. Brauer, M. Quintel, F. A. Schoendube, and H. Dorge Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery Ann. Thorac. Surg., July 1, 2007; 84(1): 110 - 119. [Abstract] [Full Text] [PDF]

				S. Mieno, M. Boodhwani, B. Ramlawi, J. Li, J. Feng, C. Bianchi, R. J. Laham, J. Li, and F. W. Sellke Human Coronary Microvascular Effects of Cardioplegia-Induced Stromal-Derived Factor-1{alpha} Ann. Thorac. Surg., August 1, 2006; 82(2): 657 - 663. [Abstract] [Full Text] [PDF]

				C. Ballard-Croft, A. C. Locklar, G. Kristo, and R. D. Lasley Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H658 - H667. [Abstract] [Full Text] [PDF]

				B. Molavi, J. Chen, and J. L. Mehta Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H687 - H693. [Abstract] [Full Text] [PDF]

				S. L. House, K. Branch, G. Newman, T. Doetschman, and J. E. J. Schultz Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2167 - H2175. [Abstract] [Full Text] [PDF]

				A. S. Aharon, M. R. Mulloy, D. C. Drinkwater Jr, O. B. Lao, M. D. Johnson, M. Thunder, C. Yu, and P. Chang Cerebral activation of mitogen-activated protein kinases after circulatory arrest and low flow cardiopulmonary bypass Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 912 - 919. [Abstract] [Full Text] [PDF]

				A. Aleshin, Y. Sawa, M. Ono, T. Funatsu, S. Miyagawa, and H. Matsuda Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 974 - 980. [Abstract] [Full Text] [PDF]

				G. G. Corbucci, C. Perrino, G. Donato, A. Ricchi, B. Lettieri, G. Troncone, C. Indolfi, M. Chiariello, and E. V. Avvedimento Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion J. Am. Coll. Cardiol., June 2, 2004; 43(11): 1992 - 1999. [Abstract] [Full Text] [PDF]

				T. A. Khan, C. Bianchi, M. Ruel, P. Voisine, and F. W. Sellke Mitogen-activated protein kinase pathways and cardiac surgery J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 806 - 811. [Abstract] [Full Text] [PDF]

				P. Rafiee, Y. Shi, X. Kong, K. A. Pritchard Jr, J. S. Tweddell, S. B. Litwin, K. Mussatto, R. D. Jaquiss, J. Su, and J. E. Baker Activation of Protein Kinases in Chronically Hypoxic Infant Human and Rabbit Hearts: Role in Cardioprotection Circulation, July 9, 2002; 106(2): 239 - 245. [Abstract] [Full Text] [PDF]

				M. Satoh, A. D. Parent, and J. H. Zhang Inhibitory Effect With Antisense Mitogen-Activated Protein Kinase Oligodeoxynucleotide Against Cerebral Vasospasm in Rats Stroke, March 1, 2002; 33(3): 775 - 781. [Abstract] [Full Text] [PDF]

				C. R Holleyman and D. F Larson Apoptosis in the ischemic reperfused myocardium Perfusion, December 1, 2001; 16(6): 491 - 502. [Abstract] [PDF]

				P. M. Becker, A. D. Verin, M. A. Booth, F. Liu, A. Birukova, and J. G. N. Garcia Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1500 - L1511. [Abstract] [Full Text] [PDF]

				R. M. Fryer, P. F. Pratt, A. K. Hsu, and G. J. Gross Differential Activation of Extracellular Signal Regulated Kinase Isoforms in Preconditioning and Opioid-Induced Cardioprotection J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 642 - 649. [Abstract] [Full Text]

				E. G. Araujo, C. Bianchi, K. Sato, R. Faro, X. A. Li, and F. W. Sellke Inactivation of the MEK/ERK pathway in the myocardium during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 773 - 781. [Abstract] [Full Text] [PDF]

				P. Ping and E. Murphy Role of p38 Mitogen-Activated Protein Kinases in Preconditioning : A Detrimental Factor or a Protective Kinase? Circ. Res., May 12, 2000; 86(9): 921 - 922. [Full Text] [PDF]